Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06127121
Other study ID # 2023-0328
Secondary ID NCI-2023-09557
Status Recruiting
Phase
First received
Last updated
Start date November 2, 2023
Est. completion date August 31, 2025

Study information

Verified date June 2024
Source M.D. Anderson Cancer Center
Contact Carlos Roldan, MD
Phone (713) 563-7402
Email croldan@mdanderson.org
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To look at how a digital art activity may help cancer patients improve their ability to express their distress, symptoms, and lived experience.


Description:

Primary objective: - To evaluate how engaging in a digital art activity might potentially cause changes in symptom reporting, based on pre/post self-reporting on the Edmonton Symptom Assessment System (ESAS) at time T3. Secondary objectives: - To evaluate the changes in symptom reporting, based on pre/post self-reporting on ESAS at different times of the study (T1, T2). - To evaluate how a specific creative art making activity (T3), compared to an active control condition (T2; music listening) may or may not impact reporting ESAS. - To monitor potential changes in distress disclosure, based on the self-report scoring on the Distress Disclosure Index score at T0, T2 and T3.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date August 31, 2025
Est. primary completion date August 31, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Age equal or greater than 18 years 2. Patients who are admitted in the hospital and have received a cancer diagnosis within six months to one year of the study. 3. Suffering from colorectal cancer, breast cancer, pancreatic cancer or lung cancer and receiving active treatment for their cancer. 4. Voluntary written consent. 5. Fluent in English or Spanish. Exclusion Criteria: 1. Not being able to use a digital tablet 2. Being speech impaired or vision impaired 3. Patients who are cognitively impaired and unable to read or consent for the study 4. Pregnant women

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Digital Art Activity
complete a symptom questionnaire complete another activity such as listening to meditative music for 10 minutes fill out the symptom questionnaire and engage in the digital art activity again

Locations

Country Name City State
United States MD Anderson Cancer Center Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
M.D. Anderson Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Edmonton Symptom Assessment System, (ESAS) questionnaires Score Scale (0-10) 0 No symptom-10 Worst possible through study completion; an average 1 year.
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients

External Links